![](https://investorshub.advfn.com/uicon/756666.png?cb=1598094430)
Wednesday, October 14, 2020 9:46:25 AM
Timing is certainly within range.
"Javitt answered and distanced NeuroRx from Relief" good point
"we might (MIGHT) have a positive development on the US side with Neuro where Dr. Javitt can speak more candidly on the data THEY have submitted to the FDA" good point
"I can’t see it being delivered during Swiss trading hours with RLFTF being halted" agree
I see where you're going with the whole Neuro/USA-independent perspective.
Well... one thing for sure, either way, we will at least learn something new tomorrow!
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM